Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00638547 | Intrathecal Enzyme Replacement for Hurler Syndrome | ||
| NCT02309944 | Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | ||
| NCT01681875 | Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes | ||
| NCT07541573 | GTB-5550 in Advanced Solid Tumors | ||
| NCT00005993 | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer | ||
| NCT05308316 | Sugars in Cigarettes | ||
| NCT00748163 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT05708924 | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00638820 | Reduced Intensity AlloTransplant For Osteopetrosis | ||
| NCT00176891 | Stem Cell Transplant w/Laronidase for Hurler | ||
| NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | ||
| NCT02989844 | Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT | ||
| NCT00630253 | Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia | ||
| NCT00290654 | Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ | ||
| NCT03365661 | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML | ||
| NCT02988466 | Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT | ||
| NCT05025774 | Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise | ||
| NCT00432094 | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | ||
| NCT00618540 | Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis | ||
| NCT03081780 | Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML | ||
| NCT06584929 | Rural Smoking Cessation | ||
| NCT00775931 | Allogeneic Transplantation For Severe Osteopetrosis | ||
| NCT07070726 | UNTOLD Ovarian Cancer Unmet Needs Survey | ||
| NCT07560865 | First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma | ||
| NCT00303667 | Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | ||
| NCT02693665 | Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer | ||
| NCT02395822 | MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients | ||
| NCT00176917 | Stem Cell Transplantation for Hurler | ||
| NCT01652092 | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders | ||
| NCT00963872 | Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer | ||
| NCT00006451 | Bone Marrow Transplantation in Treating Patients With Leukemia | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT00882206 | Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia | ||
| NCT02722668 | UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep | ||
| NCT05123040 | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids | ||
| NCT04714372 | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia | ||
| NCT05120570 | PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation | ||
| NCT01560923 | Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer | ||
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | ||
| NCT00617929 | Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant | ||
| NCT05114837 | Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL | ||
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | ||
| NCT00369291 | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT05338658 | Study of PAT in Patients With Solid Tumor Cancers | ||
| NCT00455312 | Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA | ||
| NCT01163201 | T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies |
